Anne Nunes - 19 Jun 2023 Form 3/A Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
SVP, Chief Operations Officer
Signature
/s/ Anne Nunes
Issuer symbol
ANIK
Transactions as of
19 Jun 2023
Net transactions value
$0
Form type
3/A
Filing time
12 Jan 2024, 16:35:28 UTC
Date Of Original Report
26 Jun 2023
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ANIK Common Stock 4,777 19 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3 amendment is being filed solely to correct the original Form 3 filed on June 26, 2023. The Amount of Securities Beneficially Owned under Table I, Column 2 was incorrectly reported as 3,293 shares in the original Form 3, and affected the reported amount in subsequent Form 4 filings.